Double maintains 1 strategies that include ALDX - Aldeyra Therapeutics, Inc.
Current Value
$2.101 Year Return
Current Value
$2.101 Year Return
Finnhub
NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton at...
Yahoo
LEXINGTON, Mass., May 05, 2025--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the achievement of the primary endpoint in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber trial of 0.25% reproxalap ophthalmic solution, an investigational new drug candidate, for the treatment of dry eye disease. For the prespecifie
Yahoo
LEXINGTON, Mass., May 05, 2025--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Tuesday, May 6, 2025, at 8:00 a.m. ET to announce topline results from Phase 3 dry eye disease clinical trials of reproxalap. The dial-in numbers are (833) 470-1428 for domestic callers and (404) 975-4839 for international callers. The access code is 127477. A live audio webcast of the conference call will also be accessible from the "Investors & Media
Finnhub
Aldeyra Therapeutics Inc: * ALDEYRA THERAPEUTICS INC - NEW DRUG APPLICATIONRESUBMISSION ISANTICIPATED MID-2025 * ALDEYRA THERAPEUTICS ACHIEVES PRIMARY ENDPOINT IN PHASE...
Finnhub
LOS ANGELES, April 29, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Aldeyra...
Finnhub
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Aldeyra Therapeutics, Inc. resulting from allegations...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -41.37% | $361.41M | 1.43% |
VIXY | -30.16% | $109.64M | 0.85% |
IVOL | -24.07% | $353.94M | 1.02% |
NEAR | -21.83% | $3.26B | 0.25% |
TAIL | -20.44% | $140.49M | 0.59% |
STIP | -20.23% | $11.88B | 0.03% |
VTIP | -20.05% | $14.78B | 0.03% |
FXC | -19.63% | $87.40M | 0.4% |
STPZ | -18.55% | $446.46M | 0.2% |
IYK | -17.19% | $1.48B | 0.4% |
TDTT | -16.97% | $2.47B | 0.18% |
DFNM | -16.16% | $1.53B | 0.17% |
MEAR | -15.98% | $1.03B | 0.25% |
SCHO | -15.46% | $10.87B | 0.03% |
VUSB | -15.00% | $5.30B | 0.1% |
SHY | -13.47% | $24.03B | 0.15% |
VGSH | -13.21% | $22.38B | 0.03% |
CARY | -12.52% | $347.36M | 0.8% |
FXY | -12.41% | $838.61M | 0.4% |
CLOI | -12.38% | $1.07B | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPLV | 0.04% | $7.90B | 0.25% |
MMIN | -0.04% | $469.53M | 0.3% |
VCRB | -0.05% | $2.82B | 0.1% |
JBND | 0.10% | $1.92B | 0.25% |
AGGH | -0.18% | $309.35M | 0.29% |
FXB | 0.18% | $82.87M | 0.4% |
SUB | 0.23% | $9.40B | 0.07% |
BSCQ | 0.26% | $4.21B | 0.1% |
JMBS | -0.32% | $5.40B | 0.22% |
FIXD | -0.34% | $3.54B | 0.65% |
VMBS | 0.36% | $14.29B | 0.03% |
IBDR | -0.42% | $3.25B | 0.1% |
VCSH | -0.46% | $34.94B | 0.03% |
BIV | 0.48% | $22.85B | 0.03% |
HDV | 0.51% | $10.94B | 0.08% |
GDXJ | 0.53% | $5.00B | 0.52% |
BILS | -0.55% | $3.96B | 0.1356% |
IBDQ | 0.59% | $3.08B | 0.1% |
NFRA | 0.60% | $2.38B | 0.47% |
IBD | -0.60% | $380.12M | 0.43% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCK | -29.82% | $88.42B | +27.17% | 0.39% |
KR | -24.67% | $44.68B | +24.17% | 1.89% |
COR | -24.17% | $55.43B | +28.90% | 0.56% |
TEF | -19.31% | $27.20B | +8.80% | 6.44% |
EXC | -19.08% | $43.84B | +12.45% | 3.59% |
CME | -19.01% | $98.74B | +28.80% | 3.84% |
BTI | -18.99% | $90.76B | +31.13% | 7.29% |
DUK | -18.48% | $90.12B | +12.74% | 3.61% |
KO | -18.35% | $308.23B | +13.09% | 2.75% |
CBOE | -18.30% | $22.95B | +20.67% | 1.12% |
PGR | -18.27% | $164.82B | +35.81% | 1.74% |
UL | -18.02% | $154.65B | +14.37% | 3.06% |
ED | -17.84% | $36.75B | +5.26% | 3.28% |
VRSK | -16.33% | $42.99B | +22.22% | 0.53% |
FMS | -16.32% | $16.67B | +26.84% | 2.26% |
CL | -16.03% | $72.64B | -5.18% | 2.25% |
PG | -15.85% | $380.78B | -3.25% | 2.51% |
VZ | -15.47% | $183.32B | +8.02% | 6.21% |
RSG | -15.12% | $76.55B | +30.51% | 0.93% |
CNC | -14.74% | $29.89B | -22.14% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTC | 40.90% | $4.48B | 0.15% |
VNM | 38.22% | $387.82M | 0.7% |
IWMY | 37.13% | $109.62M | 1.02% |
CPRJ | 36.14% | $48.43M | 0.69% |
IWC | 36.07% | $766.88M | 0.6% |
XHB | 35.57% | $1.26B | 0.35% |
XRT | 35.19% | $450.82M | 0.35% |
FXD | 35.11% | $334.25M | 0.61% |
VTWO | 34.87% | $12.07B | 0.07% |
IWM | 34.86% | $63.95B | 0.19% |
SCHA | 34.63% | $16.91B | 0.04% |
PRFZ | 34.55% | $2.33B | 0.34% |
IWO | 34.48% | $11.36B | 0.24% |
IWN | 34.44% | $11.10B | 0.24% |
XTN | 34.41% | $200.95M | 0.35% |
VIOV | 34.41% | $1.27B | 0.1% |
GSSC | 34.39% | $538.65M | 0.2% |
DFSV | 34.28% | $4.63B | 0.3% |
SPSM | 34.07% | $11.14B | 0.03% |
IAT | 34.03% | $607.11M | 0.4% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AMED | -0.02% | $3.08B | -1.30% | 0.00% |
NGL | -0.02% | $440.92M | -41.40% | 0.00% |
HDB | -0.04% | $187.13B | +30.85% | 0.95% |
MNR | 0.04% | $1.66B | -32.48% | 19.46% |
MKC | 0.06% | $20.04B | +0.35% | 2.35% |
WMK | -0.07% | $2.07B | +11.83% | 1.77% |
BVN | -0.07% | $3.68B | -15.25% | 0.00% |
EG | 0.07% | $14.63B | -11.43% | 2.33% |
SYPR | -0.09% | $37.69M | +21.48% | 0.00% |
DRD | 0.12% | $1.23B | +63.69% | 2.01% |
TRI | -0.14% | $85.44B | +10.89% | 1.20% |
CCEC | -0.14% | $1.02B | +3.91% | 2.71% |
NNVC | -0.14% | $20.49M | -41.26% | 0.00% |
NFG | -0.16% | $7.32B | +43.17% | 2.54% |
EDU | -0.17% | $7.99B | -41.11% | 0.00% |
OMAB | -0.18% | $4.23B | +13.53% | 4.66% |
USM | 0.18% | $5.19B | +38.83% | 0.00% |
CM | 0.21% | $61.83B | +34.39% | 4.07% |
TPVG | 0.21% | $272.08M | - | 20.03% |
OR | 0.23% | $4.33B | +41.84% | 0.82% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FC | 52.17% | $306.64M | -39.32% | 0.00% |
RXST | 51.73% | $540.88M | -78.62% | 0.00% |
SN | 43.76% | $14.13B | +37.55% | 0.00% |
RH | 41.57% | $4.08B | -23.93% | 0.00% |
RGP | 41.49% | $178.24M | -53.17% | 10.35% |
VSH | 41.38% | $2.05B | -36.62% | 2.67% |
LFUS | 40.94% | $5.35B | -13.23% | 1.28% |
LOGI | 40.92% | $13.03B | -1.65% | 1.60% |
W | 40.18% | $4.97B | -43.57% | 0.00% |
URBN | 39.99% | $5.72B | +48.45% | 0.00% |
HVT | 39.50% | $342.12M | -28.30% | 6.02% |
ETD | 38.22% | $700.34M | -6.32% | 5.67% |
UA | 38.15% | $2.67B | -6.63% | 0.00% |
SONO | 37.50% | $1.30B | -36.44% | 0.00% |
YETI | 37.34% | $2.66B | -20.79% | 0.00% |
TPG | 37.06% | $6.00B | +18.02% | 3.34% |
ICHR | 36.67% | $647.60M | -50.17% | 0.00% |
SCVL | 36.60% | $540.23M | -42.38% | 2.79% |
HOFT | 36.53% | $104.57M | -47.78% | 9.39% |
GAP | 36.24% | $9.95B | +21.46% | 2.30% |